Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Viking Therapeutics Inc buy BiotechBee

Start price
€83.00
03.03.24 / 70%
Target price
€180.00
31.05.26
Performance (%)
-16.27%
End price
€69.50
29.04.24
Summary
This prediction ended on 29.04.24 with a price of €69.50. The price of Viking Therapeutics Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -16.27%. BiotechBee has 70% into this prediction
Performance without dividends (%)
Name 1w 1m
Viking Therapeutics Inc -4.337% -4.337%
iShares Core DAX® 4.094% 4.888%
iShares Nasdaq 100 1.424% -0.445%
iShares Nikkei 225® -1.572% -4.911%
iShares S&P 500 1.822% 0.776%

According to BiotechBee what are the pros and cons of Viking Therapeutics Inc for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Viking Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) -16.27%
Target price 180.000
Change
Ends at 31.05.26

Buy mit Kursziel 180,0

In the thread Trading Viking Therapeutics Inc
Prediction Buy
Perf. (%) -16.27%
Target price 180.000
Change
Ends at 31.05.26

Buy beendet

Stopped prediction by BiotechBee for Viking Therapeutics Inc

buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€69.50
29.04.24
€100.00
31.03.26
-0.75%
03.05.24

Could be very worthwhile Investment >20% year
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€18.54
24.06.23
€27.00
31.12.25
347.68%
03.03.24

Could be very worthwhile Investment >20% year
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€6.10
19.12.22
€18.00
31.12.24
226.15%
05.05.23

Could be very worthwhile Investment >20% year